Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Recurrence, Local × Rhenium × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Neoplasm Recurrence, Local 1 Lung Neoplasms 1 Carcinoma, Small Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

motexafin gadolinium 1 Rhenium 1 Erlotinib Hydrochloride 1 Bevacizumab 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00100256 2022-11-07

Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy

Andarix Pharmaceuticals

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Recurrence, Local, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡